Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Academic Article
Publication Date:
2021
Iris type:
1.1 Articolo in rivista
List of contributors:
Woyach, J.; Tedeschi, A.; Munir, T.; Siddiqi, T.; Hillmen, P.; Byrd, J. C.; Ghia, P.; Mulligan, S. P.; Dai, S.; Amaya-Chanaga, C. I.; Dean, J. P.; O'Brien, S. M.; Barr, P. M.
Published in: